The purpose of this study is to evaluate the safety and efficacy of K-604 for the treatment of atherosclerosis.
Inclusion Criteria:
Exclusion Criteria:
Chandler, Arizona, United States
Litchfield Park, Arizona, United States
Phoenix, Arizona, United States
Los Angeles, California, United States
San Diego, California, United States
Clearwater, Florida, United States
Jacksonville, Florida, United States
St Louis, Missouri, United States
Buffalo, New York, United States
Oklahoma City, Oklahoma, United States
Carrollton, Texas, United States
Dallas, Texas, United States
Houston, Texas, United States
Plano, Texas, United States
Norfolk, Virginia, United States
Virginia Beach, Virginia, United States
Olympia, Washington, United States
Renton, Washington, United States
Seattle, Washington, United States